|

Androgen receptor targeted therapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Universitaire Ziekenhuizen KU Leuven1

Indications

  • Hormone Sensitive Prostate Cancer1
  • Prostate Cancer Recurrent1
  • Oligometastasis1
  • Oligometastatic Disease1
  • Prostate Cancer Metastatic1

Other1 trial

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.